flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry cormedix inc announces changes to board of directors  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search see headlines for crmd view print version more from accesswire cormedix inc provides comprehensive pipeline update during research and development day cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors cormedix inc to showcase its taurolidinebased development pipeline at research and development day referenced stocks crmd  rate it cormedix inc announces changes to board of directors by accesswire  june    am edt vote up a a a bedminster nj  accesswire  june   cormedix inc nyse mktcrmd a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease today announced that it will make certain changes to the composition of its board of directors over the next several weeks these changes result from a constructive dialogue among the board management and interested shareholders who have expressed dissatisfaction with a number of areas including the recent financing the changes are intended to help ensure the longterm success of the company effective immediately cora tellez has resigned her position as board chair and as a member of the board ms tellez joined the board in april  and was elected chair in may  in addition the company announced that michael george has agreed to resign his position as a member of the board to be effective as of the date on which the board appoints the two new members who will backfill ms tellezs resignation and the contemplated resignation of mr george respectively mr george has served as a director for cormedix since february  khoso baluch cormedix chief executive officer and a member of the board stated we thank cora for her dedicated service and guidance as our board chair she provided significant insight and supported the company at a critical time in our history as we entered late stage clinical development of neutrolin in the united states we respect and value coras desire to focus on her family and on other personal and professional matters at this time we also thank mike for his continued service and support until we appoint additional board members who will bring relevant expertise as we pursue fda approval and us commercialization of neutrolinâ as previously indicated the company has identified and is pursuing outstanding candidates in its ongoing searches for two board candidates with recognized applicable financial and clinical expertise with the goal of bringing this process to a successful conclusion as quickly as possible the company will continue to engage in constructive dialogue with its shareholders and remains committed to achieving a timely and successful conclusion of the phase  neutrolin trial about cormedix inc cormedix inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease the company is focused on developing its lead product neutrolin® a novel nonantibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters such infections cost the us healthcare system approximately  billion annually and contribute significantly to increased morbidity and mortality neutrolin is currently in a phase  clinical trial in patients undergoing chronic hemodialysis via a central venous catheter the company is planning to conduct its second phase  clinical trial in patients with cancer receiving iv parenteral nutrition chemotherapy and hydration via a chronic central venous catheter subject to sufficient resources if successful the two pivotal studies may be submitted to the fda for potential approval for both patient populations neutrolin has fda fast track status and is designated as a qualified infectious disease product which provides the potential for priority review of a marketing application by fda and allows for  additional years of qidp market exclusivity upon us approval it is already a ce marked product in europe and other territories for more information visit wwwcormedixcom forwardlooking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including with respect to possible uses of taurolidine that are subject to risks and uncertainties all statements other than statements of historical facts regarding managements expectations beliefs goals plans or cormedixs prospects future financial position financing plans future revenues and projected costs should be considered forwardlooking readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors including the ability to identify and attract qualified director candidates preclinical results are not indicative of success in clinical trials and might not be replicated in any subsequent studies or trials the risks and uncertainties associated with cormedixs ability to manage its limited cash resources and the impact on planned or future research including for additional uses for taurolidine the cost timing and results of the ongoing and planned phase  trials for neutrolin® in the us and the resources needed to commence and complete those trials obtaining additional financing to support cormedixs research and development and clinical activities and operations and the ability to retain and hire necessary personnel to staff our operations appropriately these and other risks are described in greater detail in cormedixs filings with the sec copies of which are available free of charge at the secs website at wwwsecgov or upon request from cormedix cormedix may not actually achieve the goals or plans described in its forwardlooking statements and investors should not place undue reliance on these statements cormedix assumes no obligation and does not intend to update these forwardlooking statements except as required by law for investors  media tiberend strategic advisors inc joshua drumm phd jdrummtiberendcom   janine mccargo jmccargotiberendcom   sourcecormedix inc this article appears in news headlines referenced stocks crmd latest news video login please enable javascript to view the comments powered by realtidbits related stocks articles subscribe zacks podcast highlights looking for top reit investments start here for your guide   am weyerhaeuser wy beats on q earnings lags on revenue   am validea warren buffett strategy daily upgrade report     am closex signin existing nasdaqcom member log in here by signing into to the site using any of the thirdparty services above you agree to nasdaqcoms terms of use welcome back log in using your   account switch accounts highest rated articles of last week shareholders approve major structural change to top performing yatra attains leadership position in corporate travel with the miller heiman group selects calliduscloud datahug for pipeline tractor supply company reports second quarter results spectranetics announces fda approval of stellarex™ drugcoated balloon view all highest rated todays market activity nasdaq    ▼   djia    ▲   sp     ▼   data as of jul   try for free nasdaq livequotes platform view all upcoming earnings company expected report date aapl jul   odfl jul   fb jul   tsla aug   t jul   amzn jul   vz jul   ge jul   earnings calendar closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest afrench economy expands  in the second quarter abig six leave border adjustment out of tax principles akids are training to be ceos and spies at these specialized summer camps aamericans are so uncomfortable asking for money that we’ve resorted to this instead aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     cormedix inc crmd  product pipeline analysis trends share size research report uscanada toll free home globaldata market guide cormedix inc crmd  product pipeline analysis cormedix inc crmd  product pipeline analysis published by  globaldata published date  aug  category  market guide no of pages   pages description table of content check discount  cormedix inc cormedix is a pharmaceutical company based in the us it develops and seeks to commercialize therapeutic products for the treatment of cardiac and renal dysfunction the companys therapeutic candidates for cardiorenal disease may be little molecules biologicals devices and diagnostics that enable therapy its pipeline includes crmd crmd crmd and crmd the companys product crmd is proprietary formulations of the oral iron chelator deferiprone it has rights to develop manufacture and market its product crmd worldwide cormedixs crmd is a novel gel formulation in preclinical development the company was founded in the year  cormedix is headquartered in bridgewater new jersey the us this report is a source for data analysis and actionable intelligence on the cormedix inc portfolio of pipeline products the report provides detailed analysis on each pipeline product with information on the indication the development stage trial phase product milestones pipeline territory estimated approval date and estimated launch date each pipeline product is profiled to cover information on product description function technology indication and application the report is also supplemented with a detailed company profile and information on clinical trials wherever applicable this report is built using data and information sourced from proprietary databases primary and secondary research and inhouse analysis by globaldatas team of industry experts scope detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments detailed coverage on all the pipeline products by equipment type by therapy area by development stage and by trial phase information on product milestones and pipeline territory for each product the estimated approval date and estimated launch date profile of each pipeline product with additional information on product description function technology indications and application data on relevant clinical trials and product patent details wherever applicable information on clinical trial wherever applicable is supplemented with information on trial phase trial status trial objective trial design target patients unique physician identifier primary point secondary point acronym participants inclusion participants exclusion interventions trial results trial start date trial end date study type trial site trial funding age eligibility and gender eligibility reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally design and develop your product development marketing and sales strategies exploit ma opportunities by identifying market players with the most innovative pipeline develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials stage and phase of development etc which are the next highvalue products that your competitor would add in its portfolio identify understand and capitalize table of content table of contents list of tables list of figures  key facts cormedix inc  major products and services cormedix inc pipeline products by equipment type cormedix inc pipeline products by development stage cormedix inc pipeline products by therapy area cormedix inc pipeline products by milestone summary neutrolin neutrolin product status neutrolin product description neutrolin product milestone thixotropic gel thixotropic gel product status thixotropic gel product description urine labile iron test urine labile iron test product status urine labile iron test product description cormedix inc  key competitors cormedix inc  key employees cormedix inc  locations and subsidiaries head office recent developments cormedix inc recent developments jul   cormedix announces extension of nyse amex listing may   cormedix reports q  results may   cormedix appoints randy milby as coo apr   cormedix receives nyse amex notice of delisting for noncompliance mar   cormedix reports  results nov   cormedix appoints matthew duffy to board nov   cormedix reports q  results aug   cormedix appoints steven lefkowitz to board aug   cormedix reports q  results may   cormedix reports net loss of m for q   appendix methodology about globaldata contact us disclaimer  list of table cormedix inc key facts cormedix inc key pipeline products by equipment type cormedix inc key pipeline products by therapy area cormedix inc key pipeline products by development stage cormedix inc key facts cormedix inc major products and services cormedix inc number of pipeline products by equipment type cormedix inc pipeline products by equipment type cormedix inc number of pipeline products by development stage cormedix inc pipeline products by development stage cormedix inc number of pipeline products by therapy area cormedix inc pipeline products by therapy area cormedix inc number of pipeline products by milestone summary cormedix inc pipeline products by milestone summary neutrolin  product status neutrolin  product description neutrolin  product milestone thixotropic gel  product status thixotropic gel  product description urine labile iron test  product status urine labile iron test  product description cormedix inc key employees  list of chart cormedix inc key pipeline products by equipment type cormedix inc pipeline products by equipment type cormedix inc pipeline products by development stage cormedix inc pipeline products by therapy area cormedix inc pipeline products by milestone summary  make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news trex did not sprint it walked unhackable web communication to be launched by china tetraphases antibiotic eravacycline succeeds stage clinical trial sperm count in men across developed countries declining sharply study greenland darkens with fear of rising sea level intensifying research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus stockscountryunited states index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest afrench economy expands  in the second quarter abig six leave border adjustment out of tax principles akids are training to be ceos and spies at these specialized summer camps aamericans are so uncomfortable asking for money that we’ve resorted to this instead aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest afrench economy expands  in the second quarter abig six leave border adjustment out of tax principles akids are training to be ceos and spies at these specialized summer camps aamericans are so uncomfortable asking for money that we’ve resorted to this instead aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  crmd key statistics  cormedix inc financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close cormedix inc nyse american crmd go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus cormedix inc market closed  quotes are delayed by  min jul    pm crmd quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description cormedix inc operates as pharmaceutical and medical device company that seeks to inlicense develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases the company was founded by antony e pfaffle on july   and i cormedix inc operates as pharmaceutical and medical device company that seeks to inlicense develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases the company was founded by antony e pfaffle on july   and is headquartered in bridgewater nj valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr mohammed khoso baluch   chief executive officer  director mr robert w cook   chief financial officer dr judith abrams   chief medical officer mr john l armstrong   executive vice presidenttechnical operations dr antony e pfaffle   secretary chief scientific officer  director insider actions – purchase – sale  – number of transactions  date name shares transaction value  cora m tellez director    acquisition at  per share   mohammed khoso baluch chief executive officer director    acquisition at  per share   cora m tellez director    acquisition at  per share   myron kaplan director    acquisition at  per share   robert w cook chief financial officer    acquisition at  per share   janet d dillione director    acquisition at  per share   taunia s markvicka director    acquisition at  per share   michael w george director    acquisition at  per share   cora m tellez director    acquisition at  per share   cora m tellez director    acquisition at  per share   antony e pfaffle chief scientific officer    disposition at  per share   antony e pfaffle chief scientific officer    derivativenonderivative trans at  per share   cora m tellez director    acquisition at  per share   cora m tellez director    acquisition at  per share   mohammed khoso baluch chief executive officer director    acquisition at  per share  newslatestcompanyuscrmd marketwatch news on crmd cormedixs stock plunges after warning that it may run out of cash  am march    tomi kilgore in focus sell signals but no break in price  pm april    lawrence g mcmillan newsnonmarketwatchcompanyuscrmd other news on crmd implied volatility surging for cormedix inc crmd stock options  am july    zackscom implied volatility surging for cormedix crmd stock options  am june    zackscom implied volatility surging for cormedix crmd stock options  am may    zackscom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript  pm may    seeking alpha centurylink inc ctl tripadvisor inc trip lead  notable investor filings  pm may    investorplacecom avis budget group inc car leads  notable investor filings  pm may    investorplacecom implied volatility surging for cormedix crmd stock options  am may    zackscom cormedix upsizes equity offering  shares slip   am april    seeking alpha are options traders betting on a big move in cormedix crmd stock  am march    zackscom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript  am march    seeking alpha premarket losers as of  am  am march    seeking alpha cormedix crushed after warning on cash  am march    seeking alpha is the options market predicting a spike in cormedix crmd stock  am jan    zackscom  biotechnology stocks to sell now  am dec    investorplacecom  biotechnology stocks to sell now  am nov    investorplacecom  biotechnology stocks to sell now  am nov    investorplacecom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript  am nov    seeking alpha biggest movers in manufacturing stocks now – gnca ntla bpmc mrtx  pm oct    investorplacecom hottest manufacturing stocks now – bspm nymx mnta kmph  am oct    investorplacecom can the uptrend continue for cormedix crmd  am oct    zackscom loading more headlines at a glance cormedix inc  us highway  suite  bridgewater new jersey  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue  net income m  sales growth  employees  annual report for crmd newspressreleasecompanyuscrmd press releases on crmd cormedix inc provides comprehensive pipeline update during research and development day  am july    accesswire cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors  am june    accesswire cormedix inc to showcase its taurolidinebased development pipeline at research and development day  am june    accesswire cormedix inc announces changes to board of directors  am june    accesswire cormedix inc reports first quarter financial results and provides business update  pm may    accesswire cormedix inc demonstrates sensitivity of emerging global health threat candida auris to taurolidine  am may    accesswire cormedix inc to report first quarter  financial results and provide business update  pm may    accesswire cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment option  pm may    accesswire cormedix inc increases previously announced public offering to  million  am april    accesswire cormedix inc announces  million underwritten public offering  pm april    accesswire shareholder alert levi  korsinsky llp announces an investigation concerning possible breaches of fiduciary duty by certain officers and directors of cormedix inc  pm april    businesswire  bzx cormedix inc reports update on neutrolinr phase  lockit  clinical trial  am april    accesswire cormedix inc secures first european commercial collaboration for neutrolinr  am april    accesswire cormedix inc makes nyse mkt section b public announcement  pm march    accesswire cormedix inc reports fourth quarter and full year  financial results and provides business update  am march    accesswire cormedix inc to report fourth quarter and full year  financial results and provide business update  pm march    accesswire cormedix inc appoints john l jack armstrong to senior leadership team  am march    accesswire cormedix inc announces new appointments to senior leadership team  am feb    accesswire cormedix inc announces dismissal of shareholder derivative action lawsuit and stipulation to forego appeal  am jan    accesswire cormedix to present at biotech showcase   am jan    accesswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest afrench economy expands  in the second quarter abig six leave border adjustment out of tax principles akids are training to be ceos and spies at these specialized summer camps aamericans are so uncomfortable asking for money that we’ve resorted to this instead aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cormedix inc announces changes to board of directors toll free  email email protected news room  cormedix inc announces changes to board of directors cormedix inc announces changes to board of directors bedminster nj  accesswire  june    cormedix inc nyse mkt crmd a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease today announced that it will make certain changes to the composition of its board of directors over the next several weeks these changes result from a constructive dialogue among the board management and interested shareholders who have expressed dissatisfaction with a number of areas including the recent financing the changes are intended to help ensure the longterm success of the company effective immediately cora tellez has resigned her position as board chair and as a member of the board ms tellez joined the board in april  and was elected chair in may  in addition the company announced that michael george has agreed to resign his position as a member of the board to be effective as of the date on which the board appoints the two new members who will backfill ms tellezs resignation and the contemplated resignation of mr george respectively mr george has served as a director for cormedix since february  khoso baluch cormedix chief executive officer and a member of the board stated we thank cora for her dedicated service and guidance as our board chair she provided significant insight and supported the company at a critical time in our history as we entered late stage clinical development of neutrolin in the united states we respect and value coras desire to focus on her family and on other personal and professional matters at this time we also thank mike for his continued service and support until we appoint additional board members who will bring relevant expertise as we pursue fda approval and us commercialization of neutrolinâ as previously indicated the company has identified and is pursuing outstanding candidates in its ongoing searches for two board candidates with recognized applicable financial and clinical expertise with the goal of bringing this process to a successful conclusion as quickly as possible the company will continue to engage in constructive dialogue with its shareholders and remains committed to achieving a timely and successful conclusion of the phase  neutrolin trial about cormedix inc cormedix inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease the company is focused on developing its lead product neutrolin® a novel nonantibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters such infections cost the us healthcare system approximately  billion annually and contribute significantly to increased morbidity and mortality neutrolin is currently in a phase  clinical trial in patients undergoing chronic hemodialysis via a central venous catheter the company is planning to conduct its second phase  clinical trial in patients with cancer receiving iv parenteral nutrition chemotherapy and hydration via a chronic central venous catheter subject to sufficient resources if successful the two pivotal studies may be submitted to the fda for potential approval for both patient populations neutrolin has fda fast track status and is designated as a qualified infectious disease product which provides the potential for priority review of a marketing application by fda and allows for  additional years of qidp market exclusivity upon us approval it is already a ce marked product in europe and other territories for more information visit wwwcormedixcom forwardlooking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including with respect to possible uses of taurolidine that are subject to risks and uncertainties all statements other than statements of historical facts regarding managements expectations beliefs goals plans or cormedixs prospects future financial position financing plans future revenues and projected costs should be considered forwardlooking readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors including the ability to identify and attract qualified director candidates preclinical results are not indicative of success in clinical trials and might not be replicated in any subsequent studies or trials the risks and uncertainties associated with cormedixs ability to manage its limited cash resources and the impact on planned or future research including for additional uses for taurolidine the cost timing and results of the ongoing and planned phase  trials for neutrolin® in the us and the resources needed to commence and complete those trials obtaining additional financing to support cormedixs research and development and clinical activities and operations and the ability to retain and hire necessary personnel to staff our operations appropriately these and other risks are described in greater detail in cormedixs filings with the sec copies of which are available free of charge at the secs website at wwwsecgov or upon request from cormedix cormedix may not actually achieve the goals or plans described in its forwardlooking statements and investors should not place undue reliance on these statements cormedix assumes no obligation and does not intend to update these forwardlooking statements except as required by law for investors  media tiberend strategic advisors inc joshua drumm phd email protected   janine mccargo email protected   source cormedix inc cormedix inc industry healthcare  pharmaceutical top crmd stock price  cormedix inc stock quote us nyse american  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a kids are training to be ceos and spies at these specialized summer camps a americans are so uncomfortable asking for money that we’ve resorted to this instead a french economy expands  in the second quarter a big six leave border adjustment out of tax principles a updated oil pauses ahead of us rig data but  weekly gain in sight a  weird things i found out about corporate america in my first  hours a ubs credit suisse profits up after strategy shift a student loan companies to feds tell states to stop regulating us a britishmade seedlip aims to woo the nondrinking crowd a prince william and kate middleton are hiring— though not for these weird five royal family jobs to be replaced home investing quotes stocks united states crmd overview compare quotes stock screener earnings calendar sectors crmd us nyse american join td ameritrade find a broker cormedix inc watchlist createcrmdalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones cormedixs stock plunges after warning that it may run out of cash mar   at  am et by tomi kilgore in focus sell signals but no break in price apr   at  pm et by lawrence g mcmillan cfo moves freds spherix frontier utilities jan   at  pm et on the wall street journal cfo moves pandora cormedix baja mining dec   at  pm et on the wall street journal recent news other news press releases implied volatility surging for cormedix inc crmd stock options cormedix inc crmd stock looks to be lucrative to the option traders on the back of its surging implied volatility jul   at  am et on zackscom implied volatility surging for cormedix crmd stock options cormedix crmd warrants investors attention based on moves in the options market lately jun   at  am et on zackscom implied volatility surging for cormedix crmd stock options investors need to pay close attention to cormedix crmd stock based on the movements in the options market lately may   at  am et on zackscom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript cormedixs crmd ceo khoso baluch on q  results  earnings call transcript may   at  pm et on seeking alpha centurylink inc ctl tripadvisor inc trip lead  notable investor filings centurylink inc ctl tripadvisor inc trip lead  notable investor filings may   at  pm et on investorplacecom implied volatility surging for cormedix crmd stock options investors in cormedix inc crmd need to pay close attention to the stock based on moves in the options market lately may   at  am et on zackscom avis budget group inc car leads  notable investor filings avis budget group inc car leads  notable investor filings may   at  pm et on investorplacecom implied volatility surging for cormedix crmd stock options may   at  am et on zackscom cormedix upsizes equity offering  shares slip  apr   at  am et on seeking alpha are options traders betting on a big move in cormedix crmd stock mar   at  am et on zackscom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript mar   at  am et on seeking alpha premarket losers as of  am mar   at  am et on seeking alpha cormedix crushed after warning on cash mar   at  am et on seeking alpha is the options market predicting a spike in cormedix crmd stock jan   at  am et on zackscom  biotechnology stocks to sell now dec   at  am et on investorplacecom  biotechnology stocks to sell now nov   at  am et on investorplacecom  biotechnology stocks to sell now nov   at  am et on investorplacecom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript nov   at  am et on seeking alpha biggest movers in manufacturing stocks now – gnca ntla bpmc mrtx oct   at  pm et on investorplacecom hottest manufacturing stocks now – bspm nymx mnta kmph oct   at  am et on investorplacecom cormedix inc provides comprehensive pipeline update during research and development day cormedix inc provides comprehensive pipeline update during research and development day jul   at  am et on accesswire cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors jun   at  am et on accesswire cormedix inc to showcase its taurolidinebased development pipeline at research and development day cormedix inc to showcase its taurolidinebased development pipeline at research and development day jun   at  am et on accesswire cormedix inc announces changes to board of directors cormedix inc announces changes to board of directors jun   at  am et on accesswire cormedix inc reports first quarter financial results and provides business update cormedix inc reports first quarter financial results and provides business update may   at  pm et on accesswire cormedix inc demonstrates sensitivity of emerging global health threat candida auris to taurolidine cormedix inc demonstrates sensitivity of emerging global health threat candida auris to taurolidine may   at  am et on accesswire cormedix inc to report first quarter  financial results and provide business update cormedix inc to report first quarter  financial results and provide business update may   at  pm et on accesswire cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment option cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment option may   at  pm et on accesswire cormedix inc increases previously announced public offering to  million apr   at  am et on accesswire cormedix inc announces  million underwritten public offering apr   at  pm et on accesswire shareholder alert levi  korsinsky llp announces an investigation concerning possible breaches of fiduciary duty by certain officers and directors of cormedix inc apr   at  pm et on businesswire  bzx cormedix inc reports update on neutrolinr phase  lockit  clinical trial apr   at  am et on accesswire cormedix inc secures first european commercial collaboration for neutrolinr apr   at  am et on accesswire cormedix inc makes nyse mkt section b public announcement mar   at  pm et on accesswire cormedix inc reports fourth quarter and full year  financial results and provides business update mar   at  am et on accesswire cormedix inc to report fourth quarter and full year  financial results and provide business update mar   at  pm et on accesswire cormedix inc appoints john l jack armstrong to senior leadership team mar   at  am et on accesswire cormedix inc announces new appointments to senior leadership team feb   at  am et on accesswire cormedix inc announces dismissal of shareholder derivative action lawsuit and stipulation to forego appeal jan   at  am et on accesswire cormedix to present at biotech showcase  jan   at  am et on accesswire cormedix inc cormedix inc operates as pharmaceutical and medical device company that seeks to inlicense develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases the company was founded by antony e pfaffle on july   and is headquartered in bridgewater nj see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations nov   at  am et on benzingacom competitors name chg  market cap utah medical products inc  m becton dickinson  co  b emergent biosolutions inc  b tetraphase pharmaceuticals inc  m achaogen inc  m competitor data provided by partner content trending tickers powered by amzn  spy  twtr  baba  wdc  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience crmd stock price  cormedix inc stock quote us nyse american  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a kids are training to be ceos and spies at these specialized summer camps a americans are so uncomfortable asking for money that we’ve resorted to this instead a french economy expands  in the second quarter a big six leave border adjustment out of tax principles a updated oil pauses ahead of us rig data but  weekly gain in sight a  weird things i found out about corporate america in my first  hours a ubs credit suisse profits up after strategy shift a student loan companies to feds tell states to stop regulating us a britishmade seedlip aims to woo the nondrinking crowd a prince william and kate middleton are hiring— though not for these weird five royal family jobs to be replaced home investing quotes stocks united states crmd overview compare quotes stock screener earnings calendar sectors crmd us nyse american join td ameritrade find a broker cormedix inc watchlist createcrmdalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones cormedixs stock plunges after warning that it may run out of cash mar   at  am et by tomi kilgore in focus sell signals but no break in price apr   at  pm et by lawrence g mcmillan cfo moves freds spherix frontier utilities jan   at  pm et on the wall street journal cfo moves pandora cormedix baja mining dec   at  pm et on the wall street journal recent news other news press releases implied volatility surging for cormedix inc crmd stock options cormedix inc crmd stock looks to be lucrative to the option traders on the back of its surging implied volatility jul   at  am et on zackscom implied volatility surging for cormedix crmd stock options cormedix crmd warrants investors attention based on moves in the options market lately jun   at  am et on zackscom implied volatility surging for cormedix crmd stock options investors need to pay close attention to cormedix crmd stock based on the movements in the options market lately may   at  am et on zackscom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript cormedixs crmd ceo khoso baluch on q  results  earnings call transcript may   at  pm et on seeking alpha centurylink inc ctl tripadvisor inc trip lead  notable investor filings centurylink inc ctl tripadvisor inc trip lead  notable investor filings may   at  pm et on investorplacecom implied volatility surging for cormedix crmd stock options investors in cormedix inc crmd need to pay close attention to the stock based on moves in the options market lately may   at  am et on zackscom avis budget group inc car leads  notable investor filings avis budget group inc car leads  notable investor filings may   at  pm et on investorplacecom implied volatility surging for cormedix crmd stock options may   at  am et on zackscom cormedix upsizes equity offering  shares slip  apr   at  am et on seeking alpha are options traders betting on a big move in cormedix crmd stock mar   at  am et on zackscom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript mar   at  am et on seeking alpha premarket losers as of  am mar   at  am et on seeking alpha cormedix crushed after warning on cash mar   at  am et on seeking alpha is the options market predicting a spike in cormedix crmd stock jan   at  am et on zackscom  biotechnology stocks to sell now dec   at  am et on investorplacecom  biotechnology stocks to sell now nov   at  am et on investorplacecom  biotechnology stocks to sell now nov   at  am et on investorplacecom cormedixs crmd ceo khoso baluch on q  results  earnings call transcript nov   at  am et on seeking alpha biggest movers in manufacturing stocks now – gnca ntla bpmc mrtx oct   at  pm et on investorplacecom hottest manufacturing stocks now – bspm nymx mnta kmph oct   at  am et on investorplacecom cormedix inc provides comprehensive pipeline update during research and development day cormedix inc provides comprehensive pipeline update during research and development day jul   at  am et on accesswire cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors jun   at  am et on accesswire cormedix inc to showcase its taurolidinebased development pipeline at research and development day cormedix inc to showcase its taurolidinebased development pipeline at research and development day jun   at  am et on accesswire cormedix inc announces changes to board of directors cormedix inc announces changes to board of directors jun   at  am et on accesswire cormedix inc reports first quarter financial results and provides business update cormedix inc reports first quarter financial results and provides business update may   at  pm et on accesswire cormedix inc demonstrates sensitivity of emerging global health threat candida auris to taurolidine cormedix inc demonstrates sensitivity of emerging global health threat candida auris to taurolidine may   at  am et on accesswire cormedix inc to report first quarter  financial results and provide business update cormedix inc to report first quarter  financial results and provide business update may   at  pm et on accesswire cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment option cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment option may   at  pm et on accesswire cormedix inc increases previously announced public offering to  million apr   at  am et on accesswire cormedix inc announces  million underwritten public offering apr   at  pm et on accesswire shareholder alert levi  korsinsky llp announces an investigation concerning possible breaches of fiduciary duty by certain officers and directors of cormedix inc apr   at  pm et on businesswire  bzx cormedix inc reports update on neutrolinr phase  lockit  clinical trial apr   at  am et on accesswire cormedix inc secures first european commercial collaboration for neutrolinr apr   at  am et on accesswire cormedix inc makes nyse mkt section b public announcement mar   at  pm et on accesswire cormedix inc reports fourth quarter and full year  financial results and provides business update mar   at  am et on accesswire cormedix inc to report fourth quarter and full year  financial results and provide business update mar   at  pm et on accesswire cormedix inc appoints john l jack armstrong to senior leadership team mar   at  am et on accesswire cormedix inc announces new appointments to senior leadership team feb   at  am et on accesswire cormedix inc announces dismissal of shareholder derivative action lawsuit and stipulation to forego appeal jan   at  am et on accesswire cormedix to present at biotech showcase  jan   at  am et on accesswire cormedix inc cormedix inc operates as pharmaceutical and medical device company that seeks to inlicense develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases the company was founded by antony e pfaffle on july   and is headquartered in bridgewater nj see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations nov   at  am et on benzingacom competitors name chg  market cap utah medical products inc  m becton dickinson  co  b emergent biosolutions inc  b tetraphase pharmaceuticals inc  m achaogen inc  m competitor data provided by partner content trending tickers powered by amzn  spy  twtr  baba  wdc  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » crmd  stock quote for cormedix inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices cormedix inc amex crmd us markets closed adchoices  ▼   after hours     july    pm edt delayed  minutes bats byx currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news cormedix inc provides comprehensive pipeline update during research and development day newsmorningstarcom  skin and soft tissue infections – market forecast h  mentioning key players cormedix inc valevia uk ltd wockhardt ltd medgadget  hrs ago cormedix inc crmd reviewed by analysts desotoedgecom  day ago suncoast equity management has increased its hanesbrands hbi holding cormedix crmd has  sentiment the bibey post  days ago cormedix inc crmd upgraded at zacks investment research themarketsdailycom  amc entertainment holdings inc amc sees week high fumbleboardcom  cormedix nysemktcrmd earning somewhat positive news coverage report shows breeze  implied volatility surging for cormedix inc crmd stock options zacks  mountain pacific investment advisers has lifted commerce bank cbsh stake cormedix nysemktcrmd shorts raised by  the bibey post  cormedix inc nysemktcrmd raised to “buy” at zacks investment research bns  cormedix inc provides comprehensive pipeline update during research and development day wwwaccesswirecom  cormedix inc provides comprehensive pipeline update during rese  kswo lawton ok wichita falls tx news weather sports abc  telemundo  kswo  news  cormedix inc provides comprehensive pipeline update during research and development day kxxvtv news   cormedix inc crmd stock rating upgraded by zacks investment research themarketsdailycom  cormedix nysemktcrmd earning somewhat favorable news coverage report shows breeze  cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors fox  wvuetv  cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors kxxvtv news   cormedix inc  appoints mehmood khan md and steven lefkowitz to its board of directors  traders  adchoices adchoices adchoices markets dow dow ▲    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment optionhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hrs  minssp futures dow futures nasdaq futures cormedix inc announces closing of public offering of common stock and warrants and underwriters exercise in full of overallotment optionaccesswiremay  reblogsharetweetsharebedminster nj  accesswire  may    cormedix inc nyse mkt crmd a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease today announced that it has closed its previously announced public offering of common stock and warrants the company sold and issued an aggregate of  shares of common stock tranche  warrants to purchase up to an aggregate of  shares of our common stock and tranche  warrants to purchase up to an aggregate of  shares of our common stock which includes the full exercise of the underwriters option to purchase additional shares of common stock and warrants from the companygross proceeds to the company from the sale of the shares were approximately  million before deducting underwriting discounts and commissions and estimated offering expenses the company intends to use the net proceeds of the offering for general corporate purposes including the development of neutrolin specifically the lockit and lockit clinical trials and working capital and capital expenditureshc wainwright  co acted as the sole bookrunning manager for this offeringeach tranche  warrant has an exercise price of  per share of common stock will become exercisable on any day on or after the date that cormedix publicly announces through the filing of a current report on form k that the amendment to the companys amended and restated certificate of incorporation to increase the number of authorized shares of common stock has been approved by the stockholders and has become effective the exercisable date and will expire five years following the exercisable date each tranche  warrant has an exercise price of  per share of common stock will become exercisable on the exercisable date and will expire thirteen months following the exercisable datethe securities described above were offered by the company pursuant to a shelf registration statement including a base prospectus which was previously filed with and declared effective by the securities and exchange commission the sec on april   a final prospectus supplement and the accompanying prospectus related to the offering was filed with the sec and copies can be obtained by contacting hc wainwright  co llc  park avenue new york ny  by calling  or by email at placementshcwcocom or at the secs website at httpwwwsecgovabout cormedix inccormedix inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease the company is focused on developing its lead product neutrolin® a novel nonantibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters neutrolin is currently in a phase  clinical trial in patients undergoing chronic hemodialysis via a central venous catheter the company is planning to conduct its second phase  clinical trial in patients with cancer receiving iv parenteral nutrition chemotherapy and hydration via a chronic central venous catheter subject to sufficient resources neutrolin has fda fast track status and is designated as a qualified infectious disease product it is already a ce marked product in europe and other territoriesforwardlooking statementsthis press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  that involve significant risks and uncertainties about cormedix including but not limited to statements with respect to cormedixs plans to consummate its proposed underwritten offering of common stock and warrants and the use of proceeds cormedix may use words such as may might should anticipate estimate expect projects intends plans believes and words and terms of similar substance to identify such forwardlooking statements among the important factors that could cause actual results to differ materially from those indicated by such forwardlooking statements are risks relating to among other things the use of the offering proceeds cormedixs business and financial condition and the impact of general economic industry or political conditions in the united states or internationally for additional disclosure regarding these and other risks faced by cormedix see disclosures contained in cormedixs public filings with the sec including the risk factors in the companys annual report on form k for the year ended december   and under the heading risk factors of the prospectus supplements for this offering you should consider these factors in evaluating the forwardlooking statements included in this press release and not place undue reliance on such statements the forwardlooking statements are made as of the date hereof and cormedix undertakes no obligation to update such statements as a result of new informationread morefor investors  mediatiberend strategic advisors incjoshua drumm phd jdrummtiberendcom   janine mccargo jmccargotiberendcom  source cormedix increblogsharetweetsharerecently viewedyour list is emptywhat to read nextboeing shares surge as it lifts outlook boosts buybacksafpengineer finds pattern makes millions in stocksmoney morningsponsoredsean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insidertrump’s unwitting legacy could be universal health coverageyahoo financerepublicans kill the border taxyahoo financethis will be in everyones household by banyan hillsponsoredtwitter is only famous now because of president trump nyse traderyahoo finance videogdp — what you need to know in markets on fridayyahoo financemattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insiderzuckerberg wifes ambitious secret finally exposedunewzmesponsoredwhite house comms director scaramucci im not steve bannon im not trying to suck my own ckbusiness insidera pga tour pro explained what separates jordan spieth from fellow stars like rory mcilroy and dustin johnsonbusiness insideramazon could be the first trillion dollar company nyse traderyahoo finance videodiscover it  out of  avg by k customersdiscover cardsponsoredrollsroyce motor ceo we’re not in the auto business we’re in the luxury businessyahoo financemarine dog with cancer gets tearfilled farewellassociated presstrump is acting suspicious because he ‘may be’ innocent fox news saysben i always hire a slew of lawyers when i havent done anything so it makes perfect sense 😂😂join the conversation   in the news  cormedix  prevention of cardiac renal and infectious diseases careers contact us      in the news press releases events in the news publications and presentations taurolidine cited as an emerging technology in the treatment of catheter related bloodstream infections read more at becker’s hospital review infection control  clinical quality lockit trial named in column on the risk of bloodstream infections for long term care patients undergoing dialysis read more at mcknight’s long term care corporate governance  cormedix  prevention of cardiac renal and infectious diseases careers contact us      corporate governance overview presentations and events stock information analyst coverage sec filings corporate governance faqs audit committee charter pdf code of conduct and ethics pdf compensation committee charter pdf nominating and governance committee charter pdf whistleblower hotline investors  cormedix  prevention of cardiac renal and infectious diseases careers contact us      investors overview presentations and events stock information analyst coverage sec filings corporate governance faqs cormedix inc is an emerging commercialstage biopharmaceutical company that initiated a phase iii clinical study of a novel antiinfective solution neutrolin in hemodialysis patients in the united states in december  the company seeks to inlicense develop and commercialize therapeutic products for the prevention and treatment of infectious and inflammatory diseases cormedix’s first commercial product in europe is neutrolin® a catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled cuffed central venous catheters used for vascular access in hemodialysis patients in addition to oncology patients critical care patients and patients receiving total parenteral nutrition iv hydration andor iv medications  the fda has granted fast track status to neutrolin catheter lock solution and also had designated neutrolin as a qualified infectious disease product for oncology hemodialysis and critical careintensive care patients where catheterrelated blood stream infections and clotting can be lifethreatening  the initial and planned indications aim to address significant needs in catheterbased treatments in the us and the rest of the world snnlive speaks with randy milby ceo of cormedix at the marcum  microcap conference in new york city   company  cormedix  prevention of cardiac renal and infectious diseases careers contact us      company overview management team board of directors scientific advisory board cormedix inc is a commercialstage pharmaceutical company focused on harnessing its taurolidine technology for the prevention and treatment of infectious inflammatory and other serious diseases the company’s first commercial product is neutrolin® a novel nonantibiotic antimicrobial solution with ce marking in europe for the prevention of costly and dangerous bloodstream infections associated with the use of central venous catheters such infections cost the healthcare system a significant amount of money annually and contribute significantly to increased morbidity and mortality  neutrolin was shown to reduce the infection rate by  compared to historical benchmarks in a postce marking observational study  cormedix is developing neutrolin as a drug in the united states and is currently in phase  clinical development in patients undergoing chronic hemodialysis via  a central venous catheter neutrolin was granted fda fast track status and is designated as a qualified infectious disease product contributing to up to  years of market exclusivity upon potential us approval  in parallel cormedix is working to create additional value for its taurolidinebased technology by establishing partnerships in the antimicrobialantiinflammatory medical device space as well as oncology home  cormedix  prevention of cardiac renal and infectious diseases careers contact us    harnessing taurolidine technology for the prevention and treatment of infectious inflammatory and other serious diseases neutrolin® a novel nonantibiotic antimicrobial solution in phase  development for the prevention of costly and dangerous bloodstream infections associated with the use of central venous catheters neutrolin® granted fda fast track status and is designated as a qualified infectious disease product neutrolin clinical trials latest news july   cormedix inc provides comprehensive pipeline update during research and development day june   cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors cormedix inc is a commercialstage pharmaceutical company focused on harnessing its taurolidine technology for the prevention and treatment of infectious inflammatory and other serious diseases events  cormedix  prevention of cardiac renal and infectious diseases careers contact us      events press releases events in the news publications and presentations   upcoming events cormedix inc rd day  july   – am et click here for the webcast submit online questions to cormedixtiberendcom special meeting of stockholders july   at  am eastern time  us highway  first floor conference room bedminster new jersey   past events cormedix inc annual meeting of stockholders  june   at  am eastern time  us highway  first floor conference room bedminster new jersey cormedix inc first quarter  results conference call may   httpwwwcormedixcomwpcontentuploadscormedixmp   cormedix inc fourth quarter and full year  results conference call march   biotech showcase  january   san francisco california cormedix inc third quarter  results conference call november   th annual biotech in europe forum for global partnering and investment company presentation and participation in vaccines  infectious diseases panel september   basel switzerland antiinfectives rx conference boston biotech september   pm – pm eastern time harvard medical school – joseph b martin conference center boston  rodman  renshaw th annual global investment conference september   new york city world antimicrobial resistance congress september   washington court hotel washington dc cormedix inc second quarter  results conference call august   cormedix first quarter  results may   th annual roth conference march   biotech showcase  january   faqs  cormedix  prevention of cardiac renal and infectious diseases careers contact us      faqs overview presentations and events stock information analyst coverage sec filings corporate governance faqs q when was cormedix inc’s public offering on march   cormedix announced the pricing of its initial public offering of  units at  per unit each unit consisted of two shares of cormedix common stock and a warrant to purchase one share of common stock at a price of  q what is cormedix inc’s common stock ticker symbol and what exchange is cormedix traded on cormedix’s common stock is traded on the nyse mkt under the ticker symbol crmd q what is the cusip number for cormedix inc’s common stock the cusip number for cormedix’s common stock is c q how can i purchase shares of cormedix inc common stock at this time cormedix does not have a direct purchase program cormedix stock may be purchased through a broker or a financial institution that deals in securities q who is cormedix inc’s stock transfer agent the transfer agent and registrar for cormedix’s common stock is vstock transfer llc the contact information for vstock transfer is  lafayette place woodmere new york   q when was cormedix inc incorporated cormedix inc was founded in  and is based in bedminster new jersey home  cormedix  prevention of cardiac renal and infectious diseases careers contact us    harnessing taurolidine technology for the prevention and treatment of infectious inflammatory and other serious diseases neutrolin® a novel nonantibiotic antimicrobial solution in phase  development for the prevention of costly and dangerous bloodstream infections associated with the use of central venous catheters neutrolin® granted fda fast track status and is designated as a qualified infectious disease product neutrolin clinical trials latest news july   cormedix inc provides comprehensive pipeline update during research and development day june   cormedix inc appoints mehmood khan md and steven lefkowitz to its board of directors cormedix inc is a commercialstage pharmaceutical company focused on harnessing its taurolidine technology for the prevention and treatment of infectious inflammatory and other serious diseases board of directors  cormedix  prevention of cardiac renal and infectious diseases careers contact us      board of directors overview management team board of directors scientific advisory board steven lefkowitz director  mr lefkowitz is the founder of wade capital corporation a financial advisory services company focused on small and middle markets and has been its president since june   mr lefkowitz has also served as a director of both publicly traded and privately held companies  he has been a director of ais re a privately held reinsurance company since   mr lefkowitz was a director of franklin credit management corporation formerly known as franklin credit holding corporation a public specialty consumer finance company from  through  and a director and chairman of the board of medconx inc a privately held medical devices connector company from  through   mr lefkowitz received his ab from dartmouth college in  and his mba from columbia university in   mr lefkowitz returns to the board of cormedix where as a director from august  to june  he brought his extensive experience in financing microcap biotech companies and helped the company successfully complete multiple capital raises  he served as the interim chief financial officer of cormedix from august   to july   mehmood khan md director dr khan currently serves as vice chairman and chief scientific officer of global research and development for pepsico where he leads global rd and oversees the company’s  sustainability agenda which includes plans for the further transformation of its current food and beverage portfolio as well as expansion of offerings containing positive nutrition with a focus on reaching more underserved communities and consumers with healthier choices  previously dr khan served as president of takeda pharmaceuticals’ global research  development center where he created and maintained a budget in excess of  billion for the company’s global rd pipeline excluding japan leading a team of thousands including outsourced staff  earlier in his career dr khan was a faculty member at the mayo clinic and mayo medical school in rochester mn serving as director of the diabetes endocrine and nutritional trials unit in the division of endocrinology prior to the mayo clinic dr khan spent nine years leading programs in diabetes endocrinology metabolism and nutrition for the hennepin county medical center in minneapolis his practice included extensive work with patients with diabetes requiring hemodialysis as well as parenteral nutrition  in his current and prior rd roles dr khan has recruited highly regarded scientists and medical experts launched research projects with leading universities worldwide and opened new global rd centers he also currently serves as a member of the board of directors for hemoshear therapeutics a biotechnology company focused on discovering novel biological targets and developing drugs to treat rare juvenile metabolic disorders he earned his medical degree from the university of liverpool medical school england myron kaplan director myron kaplan joined the board of cormedix in may  mr kaplan is a founding partner of kleinberg kaplan wolff  cohen pc where he has practiced corporate and securities law for more than forty years  among other responsibilities at the firm mr kaplan represents hedge funds and other companies in a broad spectrum of industries and works on financings mergers and acquisitions governance and compensation issues distribution and license agreements and joint ventures in  mr kaplan became a trustee of the lehman brothers plan holding trust he has served as a director of a number of public companies and nonprofit organizations previously he served as a member of the board of directors of sairgroup finance usa inc a subsidiary of sairgroup that had publicly issued debt securities trans world airlines inc and kitty hawk inc mr kaplan graduated from columbia college and holds a juris doctor from harvard law school khoso baluch director chief executive officer khoso baluch was appointed chief executive officer in october  mr baluch has built and led successful us and international commercial teams in the primary care specialty and hospital segments launching leading products including cialis byetta insulin devices cimzia vimpat and neupro during the  years mr baluch worked for eli lilly  co he held international positions in general management business development market access and product leadership and spanning europe the middle east and the united states at lilly as diabetes worldwide franchise head he had responsibility for guiding pipeline products from phase  to completion on the market  he oversaw a team of nearly  people responsible for the medical regulatory legal supply chain marketing pricing and reimbursement aspects of drug launches in the us and globally following his tenure at lilly mr baluch held multiple positions at ucb the global biopharmaceutical company as senior vice president  chief marketing officer and most recently serving as senior vice president  president european middle east  africa emea region since  mr baluch has been a board member of poxel a french publically traded biotech company janet d dillione director janet dillione joined the board of cormedix in august  since may of  she has served as the chief executive officer of bernoulli enterprise inc a realtime connected healthcare information technology company previously she was executive vice president and general manager of the healthcare division at nuance communications inc a leading provider of voice and language solutions for businesses and consumers around the world from june  to april  ms dillione held several senior level management positions at siemens medical solutions a global leader in medical imaging laboratory diagnostics and healthcare information technology including president and ceo of the global healthcare it division ms dillione has more than  years of experience leading global teams in the development and delivery of healthcare technology and services in that time she has acquired both financial expertise and significant senior management experience as a chief operating officer and executive officer that will allow her to be a valued addition to the company’s board of directors